IOL Chemicals and Pharmaceuticals Limited IOL Chemicals and Pharmaceuticals Limited

IOL Chemicals and Pharmaceuticals Limited

IOLCP

Rank in Stocks #10890
Established in 1986 and headquartered in Ludhiana, India, IOL Chemicals and... Established in 1986 and headquartered in Ludhiana, India, IOL Chemicals and Pharmaceuticals Limited operates as a global manufacturer and supplier of diverse pharmaceutical and chemical products. Its pharmaceutical portfolio encompasses a wide array of active pharmaceutical ingredients (APIs), featuring prominent pain and fever relievers such as ibuprofen, ibuprofen lysinate, ibuprofen sodium, and dex-ibuprofen. The company also provides other crucial APIs, including metformin hydrochloride, clopidogrel bisulphate, pantoprazole sodium, ursodeoxycholic acid, losartan potassium, gabapentin, levetiracetam, lamotrigine, and fenofibrate. These compounds are integral to treatments addressing various conditions, such as inflammation, pain relief, fever reduction, diabetes, platelet aggregation, cholesterol management, seizures, gallstones, and gastric acid inhibition. In addition to pharmaceuticals, IOL supplies specialized industrial chemicals like ethyl acetate, iso butyl benzene, acetyl chloride, and mono chloro acetic acid. These chemicals are widely utilized across numerous industries, including food processing, flexible packaging, pharmaceuticals, textiles, ink, paint, pesticides, and as chemical intermediates.
Share Price
$2.16
Last synced: 2026-11-09
Market Cap
$634.10M
Change (1 day)
11.33%
Change (1 year)
115.21%
Country

Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this

Trade IOL Chemicals and Pharmaceuticals Limited (IOLCP)

Category

Healthcare
Operating Margin for IOL Chemicals and Pharmaceuticals Limited (IOLCP)
Operating Margin as of November 2026 TTM: 9.06%
According to IOL Chemicals and Pharmaceuticals Limited's latest financial reports, its current operating margin (TTM) is 9.06%. At the end of 2025 the company had an operating margin of 5.98%.
Operating Margin history for IOL Chemicals and Pharmaceuticals Limited from 2005 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
2026 (TTM) 9.06% 51.51%
2025 5.98% -20.69%
2024 7.54% -4.31%
2023 7.88% -20.40%
2022 9.90% -65.17%
2021 28.42% 0.04%
2020 28.41% 26.94%
2019 22.38% 137.08%
2018 9.44% 1,110.26%
2017 0.78% -111.75%
2016 -6.64% -66.14%
2015 -19.61% -207.93%
2014 18.17% 51.54%
2013 11.99% 20.14%
2012 9.98% -15.21%
2011 11.77% 39.29%
2010 8.45% -1.97%
2009 8.62% -7.41%
2008 9.31% 22.82%
2007 7.58% -15.02%
2006 8.92% 38.29%
2005 6.45% 0.00%
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
19.41% -97.86%
DE
19.68% -97.83%
DE
13.26% -98.54%
JP
17.08% -98.11%
CH
14.92% -98.35%
IL
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.

Questions about IOL Chemicals and Pharmaceuticals Limited's operating margin

What is IOL Chemicals and Pharmaceuticals Limited's operating margin?

IOL Chemicals and Pharmaceuticals Limited's operating margin is 9.06%, as of Nov 2026.

What was IOL Chemicals and Pharmaceuticals Limited's operating margin in 2025?

In 2025, IOL Chemicals and Pharmaceuticals Limited's operating margin was 5.98%, compared with 7.54% in 2024.

How has IOL Chemicals and Pharmaceuticals Limited's operating margin changed since 2020?

From 2020 to 2025, IOL Chemicals and Pharmaceuticals Limited's operating margin was highest in 2021 (28.42%) and lowest in 2025 (5.98%).

How does IOL Chemicals and Pharmaceuticals Limited's operating margin compare with similar companies?

IOL Chemicals and Pharmaceuticals Limited's operating margin (9.06%) is lower than that of all 5 similar companies listed above. The highest among them is Merck KGaA, with 19.68%.